Sanofi and GSK delay COVID-19 vaccine, marking setback for global fight
U.S. · WORLD
December 11, 20204 min read872 words
Published: December 11, 2020  |  4 min read872 words
By PARIS (Reuters) -Sanofi and GlaxoSmithKline said clinical trials of their COVID-19 vaccine showed an insufficient immune response in older people, delaying its launch to late next year and marking a setback in the global fight against the pandemic.The announcement on Friday, w...
Sanofi and GSK delay COVID-19 vaccine, marking setback for global fight Read more

No article scores yet.

There are no critic or public scores for this article yet.
critic reviews: 0
public reviews: 0
No reviews
img-trusted
100%
critic score
14 reviews
img-trusted
80%
public score
74 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
0 reviews

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.